Drug Discovery 2024 – 2-4 October 2024

You are here:

Meet us at ELRIG Drug Discovery 2024, happening 2-4 October at the ExCel Arena, London.  

Attending ELRIG Drug Discovery 2024

ELRIG Drug Discovery 2024 is Europe’s premier event for drug discovery and translational research, set to take place on 2-4 October 2024 at the ExCeL Arena, London. The event brings together leading professionals from academia, industry, and the wider scientific community to explore the latest advancements in drug discovery technologies, including AI-driven approaches, novel targets, and innovative therapeutic platforms.

The conference features an impressive line-up of keynote speakers, panel discussions, and technical sessions, alongside a large exhibition hall showcasing cutting-edge tools and services.

Meet Us on Booth #C04

Drug Discovery 2024

The Charnwood Discovery team will be around to chat about how our standalone or integrated solutions can support your drug discovery program :

  • Kathy Dodgson – Senior Director of Biology
  • Dr Linos Lazarides– Director Business Development, Europe 
  • Dr Chris Peel – Business Development Manager, Europe

Interested in discussing potential collaborations or learning more about our innovative solutions? Schedule a meeting with our team by clicking the link below.

Register for ELRIG Drug Discovery 2024

Learn more about the event program and how you can attend here: 

elrig.org/portfolio/drug-discovery-2024/

Charnwood Discovery’s integrated drug discovery services offer a comprehensive and seamless approach to advancing pharmaceutical research from target identification through to preclinical candidate selection. 

Our multidisciplinary team provides expertise in medicinal chemistry, biology, computational chemistry, and ADME / DMPK, ensuring a collaborative and efficient workflow. With state-of-the-art facilities and a commitment to innovation, Charnwood Discovery supports clients in accelerating their drug discovery programs, optimizing lead compounds, and ultimately delivering high-quality candidates for clinical development.

Share this post:
LinkedIn
WhatsApp